Published in PLoS Negl Trop Dis on March 30, 2010
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol (2011) 3.16
Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One (2011) 2.01
Analysis of the transcriptional networks underpinning the activation of murine macrophages by inflammatory mediators. J Leukoc Biol (2014) 1.53
Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity. J Biol Chem (2010) 1.17
Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe (2012) 1.06
Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol (2013) 1.06
The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog (2011) 0.96
The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion. J Biol Chem (2010) 0.89
Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response. PLoS Negl Trop Dis (2012) 0.88
A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival. Cell Host Microbe (2013) 0.86
Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction. J Immunol (2014) 0.84
Translational challenges of animal models in Chagas disease drug development: a review. Drug Des Devel Ther (2015) 0.83
A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection. BMC Microbiol (2012) 0.83
A systems biological view of intracellular pathogens. Immunol Rev (2011) 0.81
Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions. BMC Genomics (2015) 0.81
Transcriptomic and nuclear architecture of immune cells after LPS activation. Chromosoma (2011) 0.81
Lipid metabolism modulation by the P2X7 receptor in the immune system and during the course of infection: new insights into the old view. Purinergic Signal (2011) 0.79
Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis Infection. PLoS One (2015) 0.79
Cortical Spreading Depression Causes Unique Dysregulation of Inflammatory Pathways in a Transgenic Mouse Model of Migraine. Mol Neurobiol (2016) 0.78
Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages. PLoS One (2014) 0.77
Is boosting the immune system in sepsis appropriate? Crit Care (2014) 0.77
Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death. PLoS Pathog (2016) 0.76
Pre-Infection Transcript Levels of FAM26F in PBMCS Inform about Overall Plasma Viral Load in Acute and Postacute Phase after SIV-Infection. J Gen Virol (2016) 0.75
Early Trypanosoma cruzi infection reprograms human epithelial cells. Biomed Res Int (2014) 0.75
Intimal pericytes as the second line of immune defence in atherosclerosis. World J Cardiol (2015) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Innate immune recognition. Annu Rev Immunol (2001) 26.65
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
IL-10 inhibits cytokine production by activated macrophages. J Immunol (1991) 13.13
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 13.05
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
The many faces of macrophage activation. J Leukoc Biol (2003) 8.95
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell (1996) 8.89
The cell biology of macrophage activation. Annu Rev Immunol (1984) 7.27
Activation of mononuclear phagocytes: fact, fancy, and future. J Immunol (1978) 6.22
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science (1992) 6.09
Macrophage polarization comes of age. Immunity (2005) 5.67
Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol (2003) 5.46
Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A (2002) 5.18
Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol (2006) 4.87
CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol (2000) 4.22
Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol (2005) 4.11
Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol (2002) 3.82
IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol (2002) 3.44
The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest (2006) 3.33
The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol (2001) 3.21
Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med (2000) 3.14
The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev (2003) 2.66
Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood (2003) 2.65
Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem (2006) 2.65
TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol (2008) 2.49
Type I IFN modulates innate and specific antiviral immunity. J Immunol (2000) 2.26
Leishmania species: models of intracellular parasitism. J Cell Sci (1999) 2.13
Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev (2003) 2.12
A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc Natl Acad Sci U S A (2004) 2.10
Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature (1993) 2.10
Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J Biol Chem (2001) 1.78
A systematic strategy for large-scale analysis of genotype phenotype correlations: identification of candidate genes involved in African trypanosomiasis. Nucleic Acids Res (2007) 1.73
Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun (2002) 1.54
Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol (2007) 1.51
Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol (2004) 1.47
Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur J Immunol (2002) 1.30
Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infect Immun (2004) 1.29
TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. J Immunol (2006) 1.28
Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur J Immunol (1998) 1.27
General suppression of macrophage gene expression during Leishmania donovani infection. J Immunol (2001) 1.25
Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J Immunol (1993) 1.25
A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta in macrophages and fibroblasts. J Immunol (2008) 1.18
Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur J Immunol (2001) 1.18
Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infect Immun (2005) 1.18
Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. J Immunol (2003) 1.15
Leishmania parasites and their ploys to disrupt macrophage activation. Curr Opin Hematol (2000) 1.13
Act1-ivating IL-17 inflammation. Nat Immunol (2007) 1.11
Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10
Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J Leukoc Biol (2002) 1.06
Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun (2007) 1.04
Analysis of macrophage activation in African trypanosomiasis. J Leukoc Biol (2001) 0.99
Transcriptional signatures of BALB/c mouse macrophages housing multiplying Leishmania amazonensis amastigotes. BMC Genomics (2009) 0.99
Cytokine-dependent and-independent gene expression changes and cell cycle block revealed in Trypanosoma cruzi-infected host cells by comparative mRNA profiling. BMC Genomics (2009) 0.98
Arginase induction promotes Trypanosoma cruzi intracellular replication in Cruzipain-treated J774 cells through the activation of multiple signaling pathways. Eur J Immunol (2004) 0.98
Macrophage and T-cell gene expression in a model of early infection with the protozoan Leishmania chagasi. PLoS Negl Trop Dis (2008) 0.98
Transcriptome profile of Trypanosoma cruzi-infected cells: simultaneous up- and down-regulation of proliferation inhibitors and promoters. Parasitol Res (2007) 0.95
Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection. J Immunol (2009) 0.88
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med (2010) 4.07
Genome-wide screen for Salmonella genes required for long-term systemic infection of the mouse. PLoS Pathog (2006) 2.95
B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci U S A (2003) 2.66
Genomic comparison of Salmonella enterica serovars and Salmonella bongori by use of an S. enterica serovar typhimurium DNA microarray. J Bacteriol (2003) 2.65
Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect Immun (2006) 2.60
Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg Med Chem Lett (2003) 2.54
Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun (2005) 2.51
IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol (2004) 2.47
Invasion of skin by Schistosoma cercariae. Trends Parasitol (2002) 2.44
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target. Nat Med (2012) 2.39
Drug discovery and development for neglected parasitic diseases. Nat Chem Biol (2006) 2.31
Proteases in parasitic diseases. Annu Rev Pathol (2006) 2.26
Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med (2007) 2.15
Molecular definition of the identity and activation of natural killer cells. Nat Immunol (2012) 1.97
Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg (2009) 1.87
A multienzyme network functions in intestinal protein digestion by a platyhelminth parasite. J Biol Chem (2006) 1.82
Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis (2009) 1.74
Microarray-based detection of Salmonella enterica serovar Typhimurium transposon mutants that cannot survive in macrophages and mice. Infect Immun (2005) 1.74
The microRNA bantam functions in epithelial cells to regulate scaling growth of dendrite arbors in drosophila sensory neurons. Neuron (2009) 1.68
NK cells and immune "memory". J Immunol (2011) 1.66
Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem (2002) 1.64
Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chem Biol Drug Des (2006) 1.61
Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun (2003) 1.60
A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei. J Biol Chem (2004) 1.57
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem (2010) 1.54
Proteomic analysis of Schistosoma mansoni cercarial secretions. Mol Cell Proteomics (2005) 1.54
A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection. Antimicrob Agents Chemother (2007) 1.54
Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog (2012) 1.52
Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. J Med Chem (2004) 1.49
IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med (2010) 1.42
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease. Antimicrob Agents Chemother (2010) 1.41
A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J Biol Chem (2004) 1.41
A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit. PLoS Negl Trop Dis (2011) 1.39
Blood 'n' guts: an update on schistosome digestive peptidases. Trends Parasitol (2004) 1.35
RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model. PLoS Negl Trop Dis (2008) 1.35
Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Mol Biochem Parasitol (2003) 1.34
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. Bioorg Med Chem Lett (2009) 1.33
RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Negl Trop Dis (2010) 1.32
Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB. J Med Chem (2008) 1.32
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole. PLoS Negl Trop Dis (2010) 1.30
Host pathogen protein interactions predicted by comparative modeling. Protein Sci (2007) 1.29
Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit. PLoS Negl Trop Dis (2009) 1.29
LuxS is required for persistent pneumococcal carriage and expression of virulence and biosynthesis genes. Infect Immun (2004) 1.26
Identification of a new class of nonpeptidic inhibitors of cruzain. J Am Chem Soc (2008) 1.26
Differential use of protease families for invasion by schistosome cercariae. Biochimie (2007) 1.24
Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes. J Biol Chem (2002) 1.22
A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia. Antimicrob Agents Chemother (2013) 1.22
A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection. Antimicrob Agents Chemother (2010) 1.22
Gene expression patterns during adaptation of a helminth parasite to different environmental niches. Genome Biol (2007) 1.20
Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica. J Biol Chem (2007) 1.19
Vinyl sulfones as antiparasitic agents and a structural basis for drug design. J Biol Chem (2009) 1.18
A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One (2009) 1.17
Proteomic analysis of skin invasion by blood fluke larvae. PLoS Negl Trop Dis (2008) 1.16
Global identification of peptidase specificity by multiplex substrate profiling. Nat Methods (2012) 1.14
The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. Proc Natl Acad Sci U S A (2005) 1.14
Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity. J Exp Med (2011) 1.14
Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent type-2 immunity to helminth infection in mice. PLoS Pathog (2012) 1.13
Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51. PLoS Negl Trop Dis (2012) 1.12
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain. Bioorg Med Chem Lett (2005) 1.11
Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10
Full-length-enriched cDNA libraries from Echinococcus granulosus contain separate populations of oligo-capped and trans-spliced transcripts and a high level of predicted signal peptide sequences. Mol Biochem Parasitol (2002) 1.09
Cysteine proteinases from distinct cellular compartments are recruited to phagocytic vesicles by Entamoeba histolytica. Mol Biochem Parasitol (2002) 1.09
Cytokine-dependent inflammatory cell recruitment patterns in the peritoneal cavity of mice exposed to the parasitic nematode Brugia malayi. Med Microbiol Immunol (2002) 1.09
Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents. Bioorg Med Chem Lett (2006) 1.07
Helminthic therapy: improving mucosal barrier function. Trends Parasitol (2012) 1.06
A parasite cysteine protease is key to host protein degradation and iron acquisition. J Biol Chem (2008) 1.06
A gene family of cathepsin L-like proteases of filarial nematodes are associated with larval molting and cuticle and eggshell remodeling. Mol Biochem Parasitol (2004) 1.06
Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol (2013) 1.06
Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis (2010) 1.05
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB. J Med Chem (2010) 1.04
The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family. Structure (2007) 1.03
MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest (2015) 1.03
Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease. Proc Natl Acad Sci U S A (2006) 1.02
Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB. Bioorg Med Chem Lett (2008) 1.02
High-throughput analysis of an RNAi library identifies novel kinase targets in Trypanosoma brucei. Chem Biol Drug Des (2011) 1.01
IrAE: an asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinus. Int J Parasitol (2007) 1.01
Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes. Bioorg Med Chem Lett (2007) 1.00
SmCB2, a novel tegumental cathepsin B from adult Schistosoma mansoni. Mol Biochem Parasitol (2002) 1.00
Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy. J Med Chem (2010) 1.00
Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases. J Med Chem (2004) 0.99
Metal compounds for the treatment of parasitic diseases. J Inorg Biochem (2008) 0.98
Hypothemycin, a fungal natural product, identifies therapeutic targets in Trypanosoma brucei [corrected]. Elife (2013) 0.98
Involvement of TNF in limiting liver pathology and promoting parasite survival during schistosome infection. Int J Parasitol (2004) 0.98
Cruzain : the path from target validation to the clinic. Adv Exp Med Biol (2011) 0.98
Biolistic transformation of Schistosoma mansoni with 5' flanking regions of two peptidase genes promotes tissue-specific expression. Int J Parasitol (2005) 0.98
Natural product libraries to accelerate the high-throughput discovery of therapeutic leads. J Nat Prod (2011) 0.97
A phagocytosis mutant of Entamoeba histolytica is less virulent due to deficient proteinase expression and release. Exp Parasitol (2006) 0.97
The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog (2011) 0.96
Divergent modes of enzyme inhibition in a homologous structure-activity series. J Med Chem (2009) 0.96
Identification of the major cysteine protease of Giardia and its role in encystation. J Biol Chem (2008) 0.95
B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells. J Immunol (2012) 0.95
The marine sponge Diacarnus bismarckensis as a source of peroxiterpene inhibitors of Trypanosoma brucei, the causative agent of sleeping sickness. J Nat Prod (2009) 0.95
Immune regulation during helminth infections. PLoS Pathog (2013) 0.95
A role for IL-22 in the relationship between intestinal helminths, gut microbiota and mucosal immunity. Int J Parasitol (2012) 0.94
A contiguous compartment functions as endoplasmic reticulum and endosome/lysosome in Giardia lamblia. Eukaryot Cell (2009) 0.94
Metabolic alterations to the mucosal microbiota in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.93
Distinct functional programming of human fetal and adult monocytes. Blood (2014) 0.93